Suppr超能文献

5-HT2A 受体及 5-HT2A/5-HT1A 受体相互作用在抑制僵住行为中的作用。

The role of 5-HT2A receptor and 5-HT2A/5-HT1A receptor interaction in the suppression of catalepsy.

机构信息

Department of Behavioral Neurogenomics, Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Science, Novosibirsk, Russia.

出版信息

Genes Brain Behav. 2010 Jul;9(5):519-24. doi: 10.1111/j.1601-183X.2010.00581.x. Epub 2010 Mar 22.

Abstract

In the present study, the 5-HT(2A) and 5-HT(1A) receptors functional activity and 5-HT(2A) receptor gene expression were examined in the brain of ASC/Icg and congenic AKR.CBAD13Mit76C mouse strains (genetically predisposed to catalepsy) in comparison with the parental catalepsy-resistant AKR/J and catalepsy-prone CBA/Lac mouse strains. The significantly reduced 5-HT(2A) receptor functional activity along with decreased 5-HT(2A) receptor gene expression in the frontal cortex was found in all mice predisposed to catalepsy compared with catalepsy-resistant AKR/J. 5-HT(2A) agonist DOI (0.5 and 1 mg/kg, i.p.) significantly reduced catalepsy in ASC/Icg and CBA/Lac, but not in AKR.CBAD13Mit76C mice. Essential increase in 5-HT(1A) receptor functional activity was shown in catalepsy-prone mouse strains in comparison with catalepsy-resistant AKR/J mice. However, in AKR.CBAD13Mit76C mice it was lower than in ASC/Icg and CBA/Lac mice. The inter-relation between 5-HT(2A) and 5-HT(1A) receptors in the regulation of catalepsy was suggested. This suggestion was confirmed by prevention of DOI anticataleptic effect in ASC/Icg and CBA/Lac mice by pretreatment with 5-HT(1A) receptor antagonist p-MPPI (3 mg/kg, i.p.). At the same time, the activation of 5-HT(2A) receptor led to the essential suppression of 5-HT(1A) receptor functional activity, indicating the opposite effect of 5-HT(2A) receptor on pre- and postsynaptic 5-HT(1A) receptors. Thus, 5-HT(2A)/5-HT(1A) receptor interaction in the mechanism of catalepsy suppression in mice was shown.

摘要

在本研究中,我们研究了 5-羟色胺(2A)和 5-羟色胺(1A)受体的功能活性以及脑内 5-羟色胺(2A)受体基因表达,研究对象为易发生僵住症的 ASC/Icg 和同基因 AKR.CBAD13Mit76C 小鼠品系(遗传易患僵住症),并与僵住症抗性 AKR/J 和易患僵住症 CBA/Lac 小鼠进行了比较。结果发现,与僵住症抗性 AKR/J 相比,所有易发生僵住症的小鼠的额皮质中 5-羟色胺(2A)受体功能活性明显降低,5-羟色胺(2A)受体基因表达减少。5-羟色胺(2A)激动剂 DOI(0.5 和 1 mg/kg,腹腔注射)可显著降低 ASC/Icg 和 CBA/Lac 小鼠的僵住症,但对 AKR.CBAD13Mit76C 小鼠无效。与僵住症抗性 AKR/J 相比,易发生僵住症的小鼠品系中 5-羟色胺(1A)受体的功能活性显著增加。然而,在 AKR.CBAD13Mit76C 小鼠中,其活性低于 ASC/Icg 和 CBA/Lac 小鼠。这表明 5-羟色胺(2A)和 5-羟色胺(1A)受体在调节僵住症方面存在相互关系。这一推测得到了证实,即预先给予 5-羟色胺(1A)受体拮抗剂 p-MPPI(3 mg/kg,腹腔注射)可预防 DOI 对 ASC/Icg 和 CBA/Lac 小鼠的抗僵住作用。同时,5-羟色胺(2A)受体的激活导致 5-羟色胺(1A)受体功能活性的显著抑制,表明 5-羟色胺(2A)受体对突触前和突触后 5-羟色胺(1A)受体的作用相反。因此,我们在小鼠中显示了 5-羟色胺(2A)/5-羟色胺(1A)受体相互作用在抑制僵住症机制中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验